Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome (CRPS).

The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for life science research. So, Merck’s decision to back out of its $1 billion ...

Qure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.

Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech innovators.

“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead researcher of the study at the University of Aberdeen. “This suggests a ...

Spain’s largest biotech conference, BIOSPAIN, is set to return to Barcelona from October 7th – 9th 2025. Global companies from different biotech sectors – health, agri-food, sustainability and ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...